Is ELV or PFE cheaper?

On trailing earnings, ELV is cheaper: ELV trades at a 17.09 P/E and PFE at 19.85.

Which has grown faster, ELV or PFE?

Over the past five years, ELV grew revenue faster — ELV at a 9.97% CAGR versus PFE at 8.22%.

Does ELV or PFE pay a bigger dividend?

ELV yields 1.71% and PFE yields 6.62% based on trailing dividends and the latest price.

Is ELV or PFE more profitable?

PFE runs the higher net margin — ELV at 2.62% versus PFE at 11.83%.

Which has been the better investment, ELV or PFE?

Over the past 10-year, ELV delivered the higher annualized total return — ELV at 13.46% versus PFE at 2.20%. Past performance doesn't predict future results.

Elevance Health Inc. (ELV) vs Pfizer Inc. (PFE)

PFE leads on 8 of 15 compared metrics, though ELV is the cheaper stock.

A side-by-side comparison of Elevance Health Inc. and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — ELV vs PFE

growth of $100 · last 25y

ELV +1865.2%PFE -35.4%ELV compounded faster

Log scale — wide-divergence pair

ELV PFE

ELV vs PFE: by the numbers

•PFE is the larger company ($148.19B vs $87.28B market cap).
•ELV trades at the lower earnings multiple (17.09 vs 19.85 P/E).
•PFE converts more revenue to profit (11.83% vs 2.62% net margin).
•ELV grew revenue faster over the past five years (9.97% vs 8.22% CAGR).
•PFE pays the higher dividend yield (6.62% vs 1.71%).

Which is better, ELV or PFE?

Metric tally: ELV 7 · PFE 8

It depends on what you're optimizing for:

ValueELV(lower P/E)

GrowthELV(faster 5Y revenue CAGR)

IncomePFE(higher dividend yield)

QualityPFE(higher ROIC)

Metrics side by side

Valuation

Metric	ELV	PFE
P/E ratio	17.09●	19.85
Forward P/E	13.75	9.21●
P/S ratio	0.44●	2.35
P/B ratio	2.02	1.65●
PEG ratio	2.56	—
EV / EBITDA	12.42	12.64
FCF yield	7.28%●	6.37%

Profitability

Metric	ELV	PFE
Gross margin	23.16%	69.35%●
Operating margin	3.81%	23.45%●
Net margin	2.62%	11.83%●
ROE	11.94%●	8.31%
ROIC	6.65%	8.84%●

Dividends

Metric	ELV	PFE
Dividend yield	1.71%	6.62%●
Payout ratio	27.24%	126.47%

Growth (annualized)

Metric	ELV	PFE
Revenue CAGR (5Y)	9.97%●	8.22%
EPS CAGR (5Y)	6.67%●	-3.78%
FCF CAGR (5Y)	-7.76%	-3.79%●
Total return CAGR (5Y)	2.33%●	-3.21%

Frequently asked

Which is better, ELV or PFE?: It depends on your goal. value: ELV (lower P/E); growth: ELV (faster 5Y revenue CAGR); income: PFE (higher dividend yield); quality: PFE (higher ROIC). Across all compared metrics, PFE leads 8 to 7.
Is ELV or PFE cheaper?: On trailing earnings, ELV is cheaper: ELV trades at a 17.09 P/E and PFE at 19.85.
Which has grown faster, ELV or PFE?: Over the past five years, ELV grew revenue faster — ELV at a 9.97% CAGR versus PFE at 8.22%.
Does ELV or PFE pay a bigger dividend?: ELV yields 1.71% and PFE yields 6.62% based on trailing dividends and the latest price.
Is ELV or PFE more profitable?: PFE runs the higher net margin — ELV at 2.62% versus PFE at 11.83%.
Which has been the better investment, ELV or PFE?: Over the past 10-year, ELV delivered the higher annualized total return — ELV at 13.46% versus PFE at 2.20%. Past performance doesn't predict future results.

Go deeper

Full ELV analysis Full PFE analysis Interactive comparison tool

Dig into the metrics

Elevance Health P/E ratio Pfizer P/E ratio Elevance Health dividend yield Pfizer dividend yield Elevance Health ROE Pfizer ROE Elevance Health operating margin Pfizer operating margin Elevance Health revenue growth Pfizer revenue growth Elevance Health free cash flow Pfizer free cash flow

Elevance Health & Pfizer appear in these rankings

Highest Dividend Yield Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.